Attertium

Attertium is an antithrombin III solution for intravenous use, designed to support blood clotting regulation. This pharmaceutical product is manufactured by Grifols Italia S.P.A. and is commonly used in clinical settings to manage certain coagulation disorders.

Attertium is primarily used to supplement antithrombin levels in individuals with deficiencies. This can be crucial for patients undergoing procedures that require careful management of blood clotting. The solution is administered intravenously and is often considered in scenarios where natural antithrombin levels are insufficient to prevent excessive clotting or bleeding.

When administered, Attertium works to restore the balance of antithrombin in the bloodstream. This can help in regulating the clotting process, which is essential for maintaining vascular health. Patients may experience improved coagulation control following treatment, though individual responses can vary.

Attertium should be handled with care, ensuring it is stored and administered under proper medical supervision. Patients with known allergies to antithrombin or any components of the solution should avoid its use. Always consult healthcare professionals for personalized advice regarding its administration.

Attertium may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also influence its effectiveness, so caution is advised.